BRAND_ANALYSIS #ILLUMINA HEALTH & PHARMA #4 OF 26 IN HEALTH & PHARMA HIGH TENSION

Illumina

· Public · Updated 09 Jul 2026 08:27 UTC
#34 of 1208 overall by tension · #4 of 26 in Health & Pharma
33 High Tension
The Silent Giant
Analysis

Illumina's 15.7% stock gain is the biggest surprise in the health bracket — this is a genomic sequencing company that has been beaten down by failed acquisitions and regulatory battles and is now bouncing. Sentiment at 0.40 and C=45 suggest cautious optimism rather than conviction. The science is still extraordinary; the business execution has been the problem.

IN THE NEWS (42 articles this week)
Illumina, Inc. (ILMN) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Bifrost Biosystems Pens Agreement with Illumina for Supply of Sequencing Chemistry for Optical Pooled Screening Platform - Business Wire
Illumina Looks To Duck DNA Rival's Renewed Antitrust Case - Law360
Cultural Score
45 / 100
Business Score
78 / 100
TREND
TENSION▂▃▃▂▂▃▃▁▂▂▃▃▃▃
CULTURAL▄▄▄▄▄▄▄▄▄▄▃▄▃▄
BUSINESS▆▆▆▆▆▆▆▄▆▆▆▆▆▆
TREND CHART
Loading...
CULTURAL BREAKDOWN
Wikipedia Momentum 15/40
News Presence 30/35
Search InterestRedistributed to other dimensions
BUSINESS BREAKDOWN
Stock Momentum 30/30
Market Position 16/25
Revenue Growth 15/25
Earnings Health 17/20
STOCK DATA
Price$187.81
30d Change+15.7%
Market Cap$28.4B
Profit Margin19.4%
BRANDS LIKE THIS
GlaxoSmithKline
C:40 B:73 T:33
Medtronic
C:46 B:76 T:30
UnitedHealthcare
C:40 B:72 T:32
Okta
C:47 B:80 T:33
Expedia
C:46 B:78 T:32
SHARE
Illumina's tension is 33. Commerce outpacing culture. sociologyofcapitalism.com/brand/illumina
SHARE ON X
EMBED
<iframe src="https://sociologyofcapitalism.com/embed/illumina.html" width="320" height="200" frameborder="0"></iframe>
Data: Wikipedia Pageviews, Google News RSS, AI Sentiment, Yahoo Finance
All scores approximate. Updated daily.
Sociology of Capitalism
Mike Litman